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E-mail address: zhu.qian@mayo.edu (Q. Zhu).The Pharmacogenomics Research Network (PGRN) is a collaborative partnership of research groups
funded by NIH to discover and understand how genome contributes to an individual’s response to
medication. Since traditional biomedical research studies and clinical trials are often conducted indepen-
dently, common and standardized representations for data are seldom used. This leads to heterogeneity
in data representation, which hinders data reuse, data integration and meta-analyses.
This study demonstrates harmonization and semantic annotation work for pharmacogenomics data
dictionaries collected from PGRN research groups. A semi-automated system was developed to support
the harmonization/annotation process, which includes four individual steps, (1) pre-processing PGRN
variables; (2) decomposing and normalizing variable descriptions; (3) semantically annotating words
and phrases using controlled terminologies; (4) grouping PGRN variables into categories based on the
annotation results and semantic types, for total 1514 PGRN variables.
Our results demonstrate that there is a signiﬁcant amount of variability in how pharmacogenomics
data is represented and that additional standardization efforts are needed. This represents a critical ﬁrst
step toward identifying and creating data standards for pharmacogenomics studies.
 2012 Elsevier Inc. All rights reserved.1. Introduction results of a case study of data dictionary standardization fromAs biomedical research becomes more collaborative, challenges
that arise when exchanging data among research groups becomes
more pronounced. One of the primary, yet most fundamental, chal-
lenges in exchanging and integrating data is to ensure that data is
both semantically (i.e., variable names and values share common
meanings) and syntactically (i.e., the data shares a common for-
mat) interoperable. Incompatibilities often arise as a result of dif-
ferences in the way research groups deﬁne and represent data.
Overcoming these barriers usually requires one-to-one mappings
and transformations between data sets. A more scalable approach
is to deﬁne and use data standards, which ensure that all data col-
lected using the standards for both the same semantic meaning
and syntactic representation. Such standards, however, can be dif-
ﬁcult to deﬁne in rapidly evolving ﬁelds of study where the types
of data and/or the relationships between them change frequently.
In those cases, standardization usually occurs after a sufﬁciently
large corpus of data has been collected and research methods begin
to converge. This manuscript describes results from the ﬁrst step of
just such a standardization process. Speciﬁcally, we describe thell rights reserved.members of the Pharmacogenomics Research Network (PGRN) [1].
PGRN is a collaborative partnership of research groups funded
by the U.S. National Institutes of Health to discover and understand
how genome contributes to an individual’s response to medication.
PGRN sites conduct very large scope of research ﬁelds, from cardio-
vascular–pulmonary diseases (including arrhythmias, hyperten-
sion, hypercholesterolemia, and asthma), cancers (including
breast and gastrointestinal tumors and childhood leukemias), neu-
ropsychiatric disorders (including depression and addiction), to
classic determinants of drug blood levels (pathways of absorption,
distribution, metabolism, elimination, and transport) [2]. There
have been more than 1000 published fundamental and clinical re-
search studies contributing signiﬁcantly to the scientiﬁc base of
knowledge in pharmacogenomics [3,4], a trend that is expected
to continue. However, traditional biomedical research studies
and clinical trials are being conducted independently, and common
and standardized representations for data are seldom used. This
leads to heterogeneity in the collected data and it hinders data re-
use, integration and meta-analyses across multiple datasets.2. Motivation
The variety of disease phenotypes are studied in the PGRN, as
well as differences in clinical systems in use at each PGRN site, lead
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speciﬁc. This not only hinders data aggregation among collaborat-
ing sites on a given study, but also complicates or prevents second-
ary use of the data, e.g., in meta-analyses.
To help overcome these issues, we performed a survey of PGRN
data dictionaries, which are repositories of information about the
data collected for a given study. Data dictionaries describe the vari-
ables used to capture data, including their meaning, origin, usage,
relationships to other variables, and format. The goals of this sur-
vey were to: (1) identify overlapping and non-overlapping vari-
ables in the PGRN data dictionaries and (2) propose standards
that establish a common semantic meaning and syntactic repre-
sentation for the data.
For example, Table 1 lists several variables, along with their def-
initions and permissible values, from the data dictionaries of two
PGRN sites. All three ﬁelds exhibit considerable variation as a re-
sult of both intra- and inter-site differences. As an example of in-
tra-site inconsistency, Site 1 deﬁnes two different variables to
capture information about ethnicity of a subject’s maternal grand-
mother, which have different names, deﬁnitions, and permissible
values. Interestingly, although the meaning of the permissible val-
ues is the same for the two variables, representation of the data is
different, i.e. one variable uses integers while the other uses text.
Inter-site differences between Sites 1 and 2 are also evident, as dif-
ferent names and permissible values are used to deﬁne the same
concept. Furthermore, and perhaps most signiﬁcantly, while the
name and description of the variables deﬁned by Site 1 indicate
the data represents ethnicity, the values are an admixture of both
ethnic and racial categories. This results in a discrepancy between
variable name/description and a list of values, which will compli-
cate interpretation and integration of the data.Table 1
Example of heterogeneity in data dictionaries: representation of race and ethnicity.
Origin Variable name Variable desc
PGRN Site 1 Race_matern_gm Ethnic backgr
biological ma
PGRN Site 1 Mat_gm_eth Maternal gra
PGRN Site 2 Race (none provid
PGRN Site 2 Ethnicity (none provid
OMB Race OMB race cat
(minimum de
OMB Ethnicity OMB ethnicit
(minimum deConcepts of race and ethnicity are distinct and well-deﬁned. In
addition, the U.S. Ofﬁce of Management and Budget (OMB) estab-
lished standards for reporting race and ethnicity information that
are already widely used [5] (Table 1). PGRN Site 2 conforms to
the OMB standard but it employs a custom coding scheme and it
lacks explicit deﬁnitions for the variables. This example illustrates
how data consistency and comparability would be improved if
both PGRN sites used the same deﬁnition and representation for
common concepts. While this is only a simple example, it is com-
mon to ﬁnd similar issues with other variables. In general, we have
found that data heterogeneity tends to increase with the complex-
ity of the data, the degree to which local coding systems are used,
and the level of informality of the data dictionary. The harmoniza-
tion effort described in this case study represents a critical ﬁrst
step toward identifying and creating data standards for pharmac-
ogenomics studies.3. Materials and methods
In this paper we demonstrate our approach to harmonize the
data dictionaries of PGRN, which is a highly diverse research
network. It emphasizes semantically annotating PGRN variables
using the controlled terminologies, where possible, to avoid unnec-
essary proliferation of proposed standards in the biomedical
research community. As shown in Fig. 1, we accomplished this task
including multiple steps: (1) pre-processing PGRN variables; (2)
decomposing and normalizing variable descriptions; (3) semanti-
cally annotating words and phrases using controlled terminolo-
gies; (4) grouping PGRN variables into categories based on
annotation results and semantic types.ription Permissible values
ound of your
ternal grandmother
8 = Not Applicable
1 = Unknown
1 = Caucasian (White)
2 = African American
3 = Hispanic
4 = Asian
5 = Native American
6 = Other
ndmothers ethnicity White
Black
Hispanic
Native american
Asian
Unknown
Other
Not applicable
ed) 1 = American Indian or Alaska Native
2 = Asian
3 = Black or African American
4 = Native Hawaiian or Paciﬁc Islander
5 = White
6 = Unknown
ed) 1 = Hispanic or Latino
2 = Not Hispanic or Latino
3 = Unknown
egory
signations)
American Indian or Alaska Native
Asian
Black or African American
Native Hawaiian or Paciﬁc Islander
White
y category
signations)
Hispanic or Latino
Not Hispanic or Latino
Fig. 1. Annotation pipeline used in this work.
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Data dictionaries were collected from PGRN research sites. To
accommodate differences in format, such as PDF, plain text, Micro-
soft Excel spreadsheets and html, and granularity of information
provided for each variable, we pre-processed each dictionary by
reformatting and ﬁlling in missing data, like missing variable
descriptions or value sets. Discussions were held with the dictio-
nary owner to obtain or clarify variable descriptions, value set con-
tents, and deﬁne abbreviations. All variables were loaded into a
MySQL database for harmonization. Each variable was assigned a
unique identiﬁer that was used throughout the entire harmoniza-
tion process.
3.2. Decomposition and normalization
To provide consistent and comparable deﬁnitions for variables
across research sites, terms from the controlled terminologies were
used to capture semantic meaning of variable descriptions. As de-
scribed below, NCBO Bioportal services were used to identify can-
didate terms. While the Bioportal service is designed to return both
exact and partial matches, it is not designed to take long phrases,
such as those typically found in data dictionaries, as input. There-
fore, variable descriptions were decomposed and normalized for
querying. For example, no annotation results were retrieved using
whole phrase ‘‘Was the patient hospitalized for heart failure’’, even
after stop words (‘‘was’’, ‘‘the’’, ‘‘for’’) were removed. Therefore, we
implemented an approach that is based on a lexical search algo-
rithm. This approach ﬁrst split each description into single words
and short phrases, then removed stop words and normalized word
form.
3.2.1. Decomposition
Variable descriptions were ﬁrst split into single words, which
were then reassembled into phrases. The words and phrases,
which we termed ‘‘mapping components’’ (MCs), were ultimately
used as query terms for the Bioportal service. For instance, a
description containing three words (‘‘A B C’’) will produce seven
MCs (A, B, C, AB, BC, AC, ABC). The length of each phrase was lim-
ited to a maximum of six single words.Table 2
Example of variable description decomposition and normalization.
Original variable Resulting Mapping Components (MCs)
Was the patient hospitalized for
heart failure
Single
words
Patient, hospitalization, heart, failure
Phrases Patient hospitalization, heart failure, pa
hospitalization for heart, hospitalization3.2.2. Stop word removal
Many words in variable descriptions are meaningless for
semantic annotation. To improve results of the Bioportal queries,
we removed all words that were contained in stop words list [6]
and common English words list [7]. We also removed MCs includ-
ing more than or equal to 50% stop words.
3.2.3. Normalization
The level of formalism in data dictionaries varies greatly. To re-
move the colloquialism in variable deﬁnitions, speech conversion
and tense normalization were implemented based on Uniﬁed Med-
ical Language System (UMLS) Specialist Lexicon [8]. This process
converted verb tense to a common base form, plural nouns to sin-
gular form, and possessive nouns to base forms using LRAGR lexi-
con. In addition, verbs, adjectives, and adverbs were converted to
nouns using LRNOM lexicon.
Table 2 shows an example of a variable description that was
decomposed and normalized. In this example, ‘‘was’’, ‘‘the’’, ‘‘for’’
were removed as stop words, and ‘‘was the’’, ‘‘the patient’’, ‘‘hospi-
talization for’’, ‘‘for heart’’, and ‘‘was the patient’’, etc. were re-
moved due to the percentage of stop words meeting or
exceeding 50%. In addition, ‘‘hospitalized’’ was converted to ‘‘hos-
pitalize’’ by LRAGR, and then converted to ‘‘hospitalization’’ by
LRNOM.
3.3. Semantic annotation and categorization
To complete semantic annotation process, MCs generated from
the previous step were used to query controlled terminologies, re-
sults were reviewed manually, and UMLS semantic types (ST) [9]
for the selected terms were used to group variables into different
categories.
3.3.1. Annotation with controlled terminologies
Based on types of data collected in pharmacogenomics domain,
SNOMED-CT [10], NDF-RT [11], NCI Thesaurus [12], RxNorm [13]
and LONIC [14] were selected as source terminologies for semantic
annotation. NCBO BioPortal [15] provides access to many biomed-
ical ontologies, including those selected for this study. An annota-
tion pipeline was developed to utilize BioPortal Web services [16],tient hospitalization for, hospitalization for heart, for heart failure, patient
for heart failure, patient hospitalization for heart failure
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annotation pipeline used for MCs obtained above to query ﬁve
ontologies selected for this study. Query results were returned in
XML format, which were loaded into a database for manual review.Fig. 3. Subset of UMLS semantic types hierarchical tree.
Table 3
Grouping UMLS semantic types into proposed domains.
Domains Relevant semantic types
Demographic Organism attribute; organism function
Medication Pharmacologic substance; clinical drug; organic chemical
Laboratory Laboratory or test result; laboratory procedure
Disorder Disease or syndrome; mental or behavioral dysfunction;
pathologic function
Smoking status Environmental effect of humans
Clinical
observation
Clinical attribute3.3.2. Annotation review
Annotation results were manually reviewed to ensure that
semantic meaning of each corresponding variable description
was captured. To facilitate such review process, a simple web
application was developed that allowed curators select the best
term(s) for annotation (Fig. 2). The web application presented all
of the terms that were returned for a given variable, using the var-
iable’s MCs as query terms. Curators reviewed each variable
description and selected term(s) that were thought to best repre-
sent semantic meaning of such variable, as indicated by the check
box in the ‘‘Accepted Mapping’’ column in Fig. 2.
Following term selection, curators determined how completely
selected terms captured semantic meaning of the variable. Each
variable was given a status of ‘‘complete mapping’’, ‘‘partial map-
ping’’ or ‘‘no mapping’’. Variables with status as ‘‘complete map-
ping’’ were used in the next step, variable categorization directly,
while those variables that were not sufﬁciently represented by
the query results were ﬂagged for further study, e.g., additional
clariﬁcation of the semantic meaning with the owner of the data
dictionary or manual annotation.3.3.3. Categorization
To facilitate harmonization process, variables were categorized
into common domains, such as demographics, medications, and
laboratory results. This was accomplished by taking advantage of
mappings that exist between terminologies that were used for
semantic annotation and UMLS semantic types (ST). UMLS ST are
organized in a hierarchical tree. As shown in Fig. 3, ‘‘Disease or Syn-
drome’’ is a child node of ‘‘Pathologic Function’’, and ‘‘Disease or
Syndrome’’ is a parent node of ‘‘Mental or Behavioral Dysfunction’’.
ST hierarchical tree also allowed us to uniformly represent annota-
tions at different levels of granularity, which is likely since differ-
ent terminologies were utilized for annotation. For example,
‘‘Atrial Fibrillation’’ is a ‘‘Disease or Syndrome’’ in NCI Thesaurus
but it is a ‘‘Pathologic Function’’ in SNOMED-CT and NDF-RT. ST
hierarchy provides a means to identify a common category (‘‘Path-
ologic Function’’) for ‘‘Atrial Fibrillation’’ across all three
terminologies.
Several domains were chosen as variable categories, which
were mapped to ST categories (Table 3), based on the types of vari-
ables that were present in data dictionaries used for this study. STFig. 2. Snapshot of ‘‘Variable Mapof a primary concept, which was determined by the manual review
of semantic annotations was then used to categorize the variable
into one of the domains. Such as, ‘‘past angina’’, the primary con-
cept ‘‘angina’’ with disorder ST is used for categorization, and
‘‘past’’ is as temporal qualiﬁer for ‘‘angina’’.
4. Results
4.1. PGRN data dictionaries
A total of 1514 variables were collected from four PGRN sites.
Following manual review, a number of variables were found to
be highly speciﬁc and therefore less likely to be reused, or repeat-
edly used across dictionaries from same site. As shown in Table 4,
84 variables were classiﬁed as site-speciﬁc, many of which repre-
sented processing state or internal ﬂags, e.g., ‘‘uploaded to data-
base’’, ‘‘Field for Skip logic’’. A total of 65 variables were found to
differ by only a time-based qualiﬁer, e.g., blood pressure at visit
1, 2, or 3, and 514 variables were repeated across dictionaries.
The latter category included instances of variables that were re-
peated to create a list, e.g., Drug 1 name, Drug 2 name, etc., and
those that were identical copies in different dictionaries, thereby
representing instances of variable reuse.ping Viewer’’ web interface.
Table 4
Number of special variables collected from PGRN sites.
Type of variable Descriptions PGRN
GROUP 1
PGRN
GROUP 2
PGRN
GROUP 3
PGRN
GROUP 4
Total
Site-speciﬁc Variables designed for internal use with site speciﬁc ﬂags 74 8 1 1 84
Differ only by
time qualiﬁer
Variables designed for recording different results retrieved for one particular event
(diagnosis, laboratory test, etc) at different time points
5 1 59 0 65
Repeated Variables with same semantic meanings 451 49 14 0 514
Unique Variables with different semantic meaning 317 409 107 18 851
Total 847 467 181 19 1514
Table 5
Decomposing and normalizing results.
PGRN GROUP 1 PGRN GROUP 2 PGRN GROUP 3 PGRN GROUP 4 Total
Total number of MCs 7389 3827 1857 54 13,127
Total number of MCs removed by stop words scanning 1203 2247 520 0 3970
Total number of MCs converted by specialist lexicon 417 348 102 1 868
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Since variable names tend to be highly abbreviated and rarely
capture the full semantics of the data that they represent, variable
descriptions were chosen as a source for semantic annotation. To
accomplish this, variable descriptions were decomposed into sin-
gle words and short phrases, normalized, and then used as query
terms to search controlled terminologies.
A total of 16,914 MCs were generated for 1514 variables used in
this study (Table 5). As described above, stop words and phrases
that contained at least 50% stop words were removed prior to exe-
cuting the query. This step reduced the number of MCs by 3970. In
addition, two Specialist Lexicons, LRAGR and LRNORM, were used
for speech and tense conversion; consequently 868 MCs were con-
verted to base forms.
4.3. Semantic annotation
4.3.1. Annotated by controlled terminologies
MCs generated from above steps were annotated by controlled
terminologies described in Section 3.3. Invoking NCBO Bioportal
RESTful API, annotation results were generated and rendered in
the XML format shown in Table 6. All results were reviewed man-
ually to determine the most matched appropriate terms.
4.3.2. Annotation review
Annotation results were reviewed by using the web application
shown in Fig. 2. For example, three MCs: ‘‘History’’, ‘‘Hypercholes-
terolemia’’, and ‘‘History of Hypercholesterolemia’’ were generated
for a variable description, ‘‘History of Hypercholesterolemia’’. Each
of these MCs was used as a query term for searching the ﬁve afore-
mentioned terminologies, results of which were reviewed by a
curator. Term selection was based both on term deﬁnition as well
as ST of the term. In this example, ‘‘Hypercholesterolemia’’ is a dis-
ease, so candidate terms that had a non-disease ST were excludedTable 6
Semantic annotation results.
PGRN GROUP 1 P
Total number of MCs 7389
Total number of mappings from ﬁve terminologies 48,509 2
Total number of mappings
LOINC 12,308
NCI Thesaurus 10,719
NDF-RT 6244
RxNORM 6758
SNOMED-CT 12,480from consideration, and ‘‘personal medical history’’ with ‘‘Clinical
Attribute’’ as ST was selected as the best term to represent the con-
cept of ‘‘history’’. Terminology preference for speciﬁc domains was
also considered as a determine factor when a given concept had
mappings to multiple terminologies. Speciﬁcally, SNOMED-CT
was preferred for representing concepts related to disease, RxNorm
was preferred for representing concepts related to medications,
and LOINC was preferred for representing concepts related to lab-
oratory tests. Finally, the example shown in Fig. 2, ‘‘History of
Hypercholesterolemia’’ was marked as a ‘‘complete mapping’’,
since the semantic meaning of the variable was completely cap-
tured using the selected terms.
Two observations became evident during the annotation step.
First, variables in this study were, in general, highly pre-coordi-
nated and therefore they required several concepts to capture their
semantic meaning. For example, it is common to record a subject’s
race in pharmacogenomics studies, since allele frequencies can
vary widely among different racial groups. Furthermore, in family
studies, it is common to record not only a primary subject’s race,
but also a race of family members. The data dictionaries used for
this study included several variables that captured the race of dif-
ferent individuals, each of which was semantically identical at both
level of the variable description (‘‘race category’’) and its permissi-
ble values, e.g., ‘‘American Indian or Alaska Native’’, ‘‘Asian’’, etc.;
see Table 1, but which differed from each other due to the term
that represented relationship of individual in question to that of
the primary subject. In these cases, it is preferable to use a generic
variables to represent the primary concept, and its set of permissi-
ble values, or value domain, then add a qualiﬁer to capture the dis-
tinguishing factor. While this may be difﬁcult to achieve on a case
report form or family history questionnaire, it is relevant to the
data models that are used to represent the information.
Secondly, many variables were captured as derived values, e.g.,
the age of the subject at diagnosis, the age of the subject at hospi-
talization, etc, rather than as primary data, e.g., birth date, date ofGRN GROUP 2 PGRN GROUP 3 PGRN GROUP 4 Total
3827 1857 54 13,127
0,652 9683 673 79,517
4852 2409 158 19,727
4801 2328 152 18,000
2813 1315 106 10,478
2838 1083 105 10,784
5348 2728 152 20,708
Table 7
Categorization results and examples for 797 variables from four PGRN groups.
Categories #
Variables
Examples
Variables MC Preferred name Concept
code
Terminologies ST
Medication 170 Drug Strength Drug Substance C459 NCI
Thesaurus
Pharmacologic substance
Strength Pharmaceutical
Strength
C53294 NCI
Thesaurus
Qualitative concept
Currently taking aspirin Aspirin Aspirin 1191 RxNorm Organic chemical
Currently Current 15240007 SNOMED CT Temporal concept
Disease disorder 146 Lone atrial ﬁbrillation Lone atrial
ﬁbrillation
Lone atrial
ﬁbrillation
233910005 SNOMED CT Disease or syndrome
History of Myocardial
Infarction
Myocardial
Infarction
Myocardial
Infarction
22298006 SNOMED CT Disease or syndrome
History Personal Medical
History
C18772 NCI
Thesaurus
Clinical attribute
Clinical
observation
71 Clinic diastolic blood
pressure
Clinic Clinic C51282 NCI
Thesaurus
Health care related organization
Diastolic blood
pressure
Diastolic blood
pressure
271650006 SNOMED CT Clinical attribute
Laboratory 69 Electrophysiology study Electrophysiology Electrophysiology LP6252-3 LOINC Laboratory procedure
Smoking status 65 What age quit smoking Age Age LP28815-6 LOINC Organism attribute
Smoking Tobacco Smoking C17934 NCI
Thesaurus
Individual behavior
Stop Stop C65125 NCI
Thesaurus
Activity
Demographics 62 Age Age Age LP28815-6 LOINC Organism attribute
Gender Gender Gender LP61312-2 LOINC Organism attribute
Other categories 214 DNA Sample Number DNA DNA LP32416-7 LOINC Nucleic acid, nucleoside, or
nucleotide
Sample Specimen C19157 NCI
Thesaurus
Physical object
Number Number C25337 NCI
Thesaurus
Quantitative concept
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capture derived values that are relevant for a particular study, it
is more difﬁcult to utilize data set for secondary purposes. Captur-
ing data as primary values simpliﬁes data integration and reuse.4.4. Categorization
Only variables with ‘‘complete mapping’’ label were moved into
this categorization step. We used the selected annotation results
with ST information and relied on human domain knowledge to
categorize variables into categories. The categories are shown in
Table 7. Note that the variables included in Table 7 were calculated
based on the 797 ‘‘unique’’ variables only (see Table 4).
It is not surprising that pharmacogenomics data sets contain a
relatively large number of variables that represent medications,
diseases, clinical observations, laboratory values, and demograph-
ics. However, it should be noted that many laboratory-based vari-
ables, such as ‘‘gamma-glutamyl hydrolase activity in diagnostic
bone marrows’’ and ‘‘R enantiomer of the primary metabolite
Desmethyl Citalopram (ng/mL)’’could not be fully annotated and
therefore categorized since there was no suitable term, e.g., LOINC
code to represent. This may be due to the fact that some laboratory
tests that are used in pharmacogenomics studies are conducted in
experimental, rather than clinical, labs. As pharmacogenomics dataTable 8
Semantic annotation results.
PGRN Groups # Variables # ‘‘complete mapp
PGRN GROUP 1 317 295
PGRN GROUP 2 409 387
PGRN GROUP 3 107 97
PGRN GROUP 4 18 18
Total # 851 797 (93.6%)is integrated into clinical practice, it may be necessary to extend
terminologies to represent new laboratory tests.
It was also striking that none of the pharmacogenomics data
dictionaries used in this study contained variables that represented
genomic data. Obviously, the research sites that provided the dic-
tionaries generate and store genomic data. The absence of these
elements in their data dictionaries may be a reﬂection of the rela-
tive immaturity of the application of pharmacogenomics data in a
clinical setting and a tendency to consider the genomic data exper-
imental. The lack of standards to represent pharmacogenomics
data may also be a factor. Clearly, this is an area for future work.
4.5. Evaluation
Domain experts inside Mayo Clinic were invited to review our
semantic annotation work, including the annotation selections and
categorization outcomes. Based on their evaluation results, we per-
formed two further evaluations to determine overall performance of
our harmonization infrastructure. Valuable evaluations by PGRN
sites have not been done, but will take place in the coming months.
4.5.1. Semantic annotation
In this evaluation step, we considered annotation results only
for the ‘‘unique’’ variables without duplicated and repeated ones.ing’’ # ‘‘partial mapping’’ # ‘‘no mapping’’
11 11
17 5
4 6
0 0
32 (3.8%) 22 (2.6%)
Table 9
Categorization results with semantic types.
Demographics Medication Laboratory Disease disorder Clinical observation Smoking status
PGRN GROUP 1 9 (69.2%) 85 (100%) 31 (72.1%) 28 (87.5%) 47 (83.9%) 5 (83.3%)
PGRN GROUP 2 23 (67.6%) 45 (84.9%) 11 (57.9%) 85 (96.6%) 4 (75%) 55 (93.2%)
PGRN GROUP 3 6 (54.5%) 24 (100%) 4 (80%) 22 (100%) 8 (100%) 0 (100%)
PGRN GROUP 4 3 (75%) 8 (100%) 2 (100%) 4 (100%) 0 (100%) 0 (100%)
Total 41 (66%) 162 (95.3%) 48 (69.6%) 139 (95.2%) 59 (83.1%) 60 (92.3%)
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captured by the annotation results selected by curators. The num-
ber of complete annotations can increase by performing additional
modiﬁcations for the variables with partial/no mapping.
4.5.2. Categorization with semantic types
A total of 583 variables were grouped into six categories based
on semantic types and domain knowledge. The matched results
displayed as numbers along with percentages are shown in Table
9. From Table 9 and 509 variables (87.3%) have been successfully
grouped into appropriate categories by ST, and 74 (12.7%) variables
were not placed in any relevant categories by ST. Main reason of
the 12.7% failure is a primary word missing in such variables, re-
sulted in no corresponding ST assigned for these variables, such
as ‘‘dose’’, ‘‘Dosing frequency’’, etc., which are missing ‘‘drug’’ as
primary word. For such cases, we manually moved them into cor-
rect groups.5. Limitation and future work
Variables from PGRN sites were not distinguished with value
sets completely, that is to say, some variables were value sets.
For example, we had ‘‘subject race’’ and ‘‘American Indian or Alas-
kan Native’’ as individual variables, and the second one should be
the value set of the ﬁrst one ‘‘subject race’’. In this work, we did
not differentiate these variables and process them separately, but
in future work we will extract value set from the mixed data sets
and combine permissible values provided by PGRN sites sepa-
rately, and then standardize and load them into LexEVS [17] for fu-
ture browsing and querying.
We aggregated and processed data from four PGRN groups, and
generated six common categories in this work. However, the work-
ﬂow reported in this paper will be used to handle datasets from
more PGRN sites; and undoubtedly, more categories will be gener-
alized on the basis of particular research focuses from these sites.
Meanwhile, site-speciﬁc variables will be taken into account in fu-
ture work.
Due to a huge portion of PGRN clinical data received currently,
in this study, we were focusing on clinical data processes, which
are relevant to laboratory test, medication, and disease. Mean-
while, we did collect some genomics sample data from particular
PGRN groups, and we expect more genomics data descriptors will
be able to be placed into our PGRN data repository in near future.
Then we will collaborate with a joint GenomicsWork Group, estab-
lished by HL7 [18] and CDISC [19] to address problems associated
with genomics data harmonization and generate PGRN speciﬁc
genomics data standards.
To ﬁll a gap between pharmacogenomics data standardization,
linkage to Electronic Medical Record (EMR) and clinical research
standards, further mappings with standardized clinical data mod-
els for each category will be taken into account. We propose to
map PGRN variables from each category to Clinical Element Model
[20], CDISC [19], Case Report Forms from caDSR [21], and PhenX
[22]. This future work will not only make PGRN variables repre-
sentable in a more standardized way, but also provide ﬂexibilityof bridging and expanding PGRN speciﬁc variables to the clinical
data models.6. Conclusion
Data and metadata standards help to mitigate problems that
arise from semantic and syntactic differences between research
groups. These differences are major barriers that hinder effective
communication among scientists and that slow the pace of
advancement and discovery. It is often difﬁcult for those in rapidly
advancing ﬁelds of study to converge on a set of standards before a
signiﬁcant volume of data is generated. This can result in the gen-
eration of large data sets that are difﬁcult to interpret, merge to-
gether, and use in downstream analyses that were not part of the
original study design. This work describes initial effort to harmo-
nize data dictionaries from pharmacogenomics research sites.
Our results demonstrate that there is a signiﬁcant amount of vari-
ability in how data is represented among PGRN sites and that a lar-
ger standardization effort is needed.
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